Literature DB >> 31416729

Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy.

Ana Martín-García1, Elena Díaz-Peláez2, Agustín C Martín-García2, Javier Sánchez-González3, Borja Ibáñez4, Pedro L Sánchez5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31416729     DOI： 10.1016/j.rec.2019.07.006

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  3 in total

1.  Successful treatment of doxorubicin-induced cardiomyopathy with low-dose sacubitril/valsartan: a case report.

Authors:  Elisabeth Bell; Alexander Desuki; Susanne Karbach; Sebastian Göbel
Journal:  Eur Heart J Case Rep       Date:  2022-09-23

2.  Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.

Authors:  Alessandro Lupi; Sara Ariotti; Doranna De Pace; Irene Ferrari; Stefano Bertuol; Lorenzo Monti; Luigina Guasti; Giovanni Vincenzo Gaudio; Carlo Campana
Journal:  Clin Med Insights Cardiol       Date:  2021-04-13

3.  Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology.

Authors:  Maria Laura Canale; Katia Coviello; Gianluca Solarino; Jacopo Del Meglio; Federico Simonetti; Elio Venturini; Andrea Camerini; Nicola Maurea; Irma Bisceglia; Carlo Tessa; Giancarlo Casolo
Journal:  Front Cardiovasc Med       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.